Introduction
The hemp industry had been watching the House Agriculture Committee’s markup of the Farm, Food, and National Security Act of 2026 as a potential vehicle for delay or relief from the November 12 compliance deadline. On March 5, 2026, that window effectively closed.
The committee voted 34-17 to advance the bill without adopting any amendments that would delay or repeal the November 2026 intoxicating hemp ban. Committee Chairman Glenn Thompson (R-PA) ruled amendments to modify the hemp ban non-germane — stating that regulating finished hemp products falls under the House Energy and Commerce Committee and FDA, not Agriculture.
For the hemp industry, the vote is a significant signal: the congressional path to legislative relief from the November 12 deadline is narrower than many operators had hoped.
Why the Committee Vote Matters
The House Agriculture Committee is the primary jurisdiction for Farm Bill provisions, including the hemp definition that underpins the November 12 compliance deadline. When hemp industry advocates were lobbying for a delay or modification to the total THC standard, the Agriculture Committee was the most natural venue for that effort.
Chairman Thompson’s ruling that hemp finished product regulations are “non-germane” to the Agriculture Committee is a jurisdictional determination with significant strategic implications. It means that any legislative relief from the November 12 hemp ban would need to come through a different congressional channel — either through the Energy and Commerce Committee, the Senate Agriculture Committee, or a standalone bill that moves outside the Farm Bill process.
Each of those paths is more uncertain and slower than a Farm Bill amendment would have been. The committee’s 34-17 vote also signals that even if amendments had been ruled germane, a majority of committee members were not prepared to modify the hemp ban.
What GOP Lawmakers Are Proposing Instead
Several Republican lawmakers have introduced standalone hemp amendments that would allow continued legal sales of hemp-derived THC products under federal law, but these proposals face significant headwinds. The proposals have not gained traction in the Senate, and the White House’s executive order directing agencies to develop hemp regulations did not include any instruction to delay the November 12 deadline.
President Trump issued an executive order in December 2025 directing aides to work with Congress on hemp regulations. But the executive order was widely interpreted as an intent to develop a post-November 12 regulatory framework rather than a delay of the deadline itself. Hemp industry advocates hoping the executive order would result in a deadline extension have largely been disappointed.
The legislative picture as of late April 2026 is: the November 12 deadline stands, there is no clear congressional vehicle for delay, and the administration’s executive order appears to be focused on post-deadline regulation rather than pre-deadline relief.
The Energy and Commerce Committee Path
Chairman Thompson’s ruling that finished hemp product regulations belong to Energy and Commerce rather than Agriculture is not simply a procedural dodge — it reflects a genuine jurisdictional question about how to classify hemp-derived consumable products. Energy and Commerce oversees FDA, which has its own ongoing jurisdictional questions about hemp-derived CBD in food and dietary supplements.
For the hemp industry, this creates an opening: advocacy directed at Energy and Commerce Committee members, combined with FDA rulemaking pressure, represents a potential legislative path. But this path is longer, more uncertain, and less likely to produce results before November 12 than a Farm Bill amendment would have been.
Industry observers watching the Energy and Commerce path should note that FDA’s track record on hemp rulemaking is not encouraging. The agency missed its own internal 2022 deadline for hemp CBD regulatory guidance and has been slow to act on the sector despite sustained industry pressure.
What This Means for Business Planning
For hemp operators, the March 5 committee vote removes the most plausible scenario for legislative delay of the November 12 deadline. That has direct implications for how businesses should be planning:
Treat November 12 as certain. Any business plan that assumed a congressional delay as a likely outcome needs to be revised. The probability of meaningful legislative relief before November 12 is now low enough that it should not be a primary planning assumption.
Focus compliance resources on operational readiness, not regulatory advocacy. While industry associations will continue to pursue legislative and regulatory relief, individual hemp businesses should invest their limited time and resources in compliance preparation rather than waiting for a political outcome that may not materialize.
The post-November 12 landscape is where the legislative action may unfold. The executive order’s focus on post-deadline regulation suggests that there may be more flexibility in how the federal government implements and enforces the new standard after November 12 than in the standard itself. Businesses that have made a good-faith compliance effort will be better positioned to benefit from any post-deadline regulatory evolution.
🌿 LGH Perspective
At Low Gravity Hemp, we’ve been operating on the assumption that November 12 is real since the 2025 Continuing Resolution established the deadline. The committee vote confirms what we’ve believed all along: the time to prepare is now, not after a hoped-for legislative rescue that isn’t coming. Our B2B customers who are making compliance decisions today will be the ones with operational continuity in November. Those waiting for congressional relief may find there’s no runway left.
Final Thoughts
The House Agriculture Committee’s 34-17 vote to advance the Farm Bill without any hemp ban modification is the clearest congressional signal yet that November 12 is not moving. The jurisdictional ruling to Energy and Commerce opens a theoretical path but not a practical one before the deadline.
For hemp businesses, the strategic implication is unambiguous: plan for November 12, not around it.
Contact Low Gravity Hemp to source compliant hemp ingredients and build your November 12 readiness plan.
